Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
19 Results for "
acarbose
" in MedChemExpress (MCE) Product Catalog:
Products (19)
19 Results for "acarbose" in MCE Product Catalog:
13
Category:
Polysaccharides Microorganisms Anti-aging Metabolic Disease Disease Research Fields Saccharides
Target:
Cat. No.: HY-B0089R
CAS No.: 56180-94-0
Synonyms: BAY g 5421 (Standard)
Category:
Target:
Cat. No.: HY-B0089S
CAS No.: 1260619-60-0
Synonyms: BAY g 5421-d4
Cat. No.: HY-B0089A
CAS No.: 1221158-13-9
Synonyms: Bay-g 5421 sulfate
Target:
Cat. No.: HY-131504A
CAS No.: 38231-86-6
Target:
Research Areas:
Valienamine is the alpha-glucosidase inhibitor. Valienamine is the key functional component of many natural glycosidase inhibitors including the crop protectant validamycin A and the antidiabetic agent acarbose .
Cat. No.: HY-121323R
CAS No.: 4430-36-8
Target:
Research Areas:
Acarbose (Standard) is the analytical standard of Acarbose. This product is intended for research and analytical applications. Acarbose (BAY g 5421), antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Acarbose can potentiate the hypoglycemic effects of sulfonylureas or insulin .
Cat. No.: HY-161782
CAS No.: 3049575-16-5
Target:
Research Areas:
α-Amylase-IN-7 (Compound 6e) is an inhibitor for α-Amylase with an IC50 of 40 μM. α-Amylase-IN-7 exhibits potential as an antidiabetic agent .
Cat. No.: HY-E72048
Target:
Research Areas:
Acarbose 7IV-phosphotransferase (EC 2.7.1.187) is a transferase that can convert acarbose and ATP into acarbose 7(IV)-phosphate, ADP and H +.
Cat. No.: HY-168462
Target:
Research Areas:
α-Glucosidase-IN-82 (compound 8l) is a potent inhibitor of α-Glucosidase, with the IC50 of 13.66 μM. α-Glucosidase-IN-82 exhibits a 52-fold increase in inhibitory activity relative to Acarbose (HY-B0089) .
Cat. No.: HY-162639
CAS No.: 1624628-01-8
Research Areas:
α-Glucosidase-IN-68 (Compound 2) is an inhibitor for α-Glucosidase, AChE, and BChE, with IC50 of 0.251, 0.774 and 0.793 μM, respectively. α-Glucosidase-IN-68 exhibits antioxidant efficacy, with IC50 of 0.69 μM and 0.02 μM, in DPPH and ABTS experiments. α-Glucosidase-IN-68 exhibits antidiabetic effect in Streptozotocin (HY-13753)-induced diabetic rat models .
Cat. No.: HY-147718
CAS No.: 111316-33-7
Target:
Research Areas:
α-Glucosidase-IN-5 (compound 8) is a potent α-glucosidase inhibitor with an IC50 of 57.9 µM. α-Glucosidase-IN-5 has the potential for the research of diabetes mellitus .
Cat. No.: HY-147964
CAS No.: 735273-33-3
Target:
Research Areas:
α-Glucosidase-IN-9 (compound 7) is a potent α-glucosidase inhibitor, with an IC50 of 55.6 μM. α-Glucosidase-IN-9 can be used for type II diabetes research .
Cat. No.: HY-147965
CAS No.: 2586282-68-8
Target:
Research Areas:
α-Glucosidase-IN-10 (compound 13) is a potent α-glucosidase inhibitor, with an IC50 of 92.7 μM. α-Glucosidase-IN-10 can be used for type II diabetes research .
Cat. No.: HY-170606
Target:
Research Areas:
α-Glucosidase-IN-79 (Compound 4d9) is a non-competitive α-Glucosidase inhibitor with an IC50 of 2.11 μM, which is more potent than existing α-Glucosidase inhibitors such as Acarbose (HY-B0089) (IC50 of 327.0 μM) and HXH8r (IC50 of 15.32 μM). α-Glucosidase-IN-79 is non-cytotoxic to human normal hepatocyte (LO2) cells and shows good metabolic stability in rat plasma. α-Glucosidase-IN-79 holds promise for research into type 2 diabetes .
Cat. No.: HY-176221
Target:
Research Areas:
α-Glucosidase-IN-92 (compound 14b) is a non-competitive inhibitor targeting α-glucosidase (IC50=64.0 μM), with better inhibitory potency than Acarbose (HY-B0089) (IC50=750 μM). α-Glucosidase-IN-92 has good oral bioavailability and can cross the blood-brain barrier. α-Glucosidase-IN-92 can delay carbohydrate hydrolysis and reduce postprandial blood glucose. α-Glucosidase-IN-92 can be used in anti-glycemic research for type 2 diabetes .
Cat. No.: HY-178170
Target:
Research Areas:
α-Amylase/α-Glucosidase-IN-22 is an inhibitor of α-Amylase and α-Glucosidase with IC50 values of 1.71 and 10.36 nM (5 and 23.8 folds more potent than Acarbose (HY-B0089)). α-Amylase/α-Glucosidase-IN-22 can be used for the researches of metabolic disease, such as diabetes .
Cat. No.: HY-E71525
Target:
Research Areas:
2-epi-5-epi-Valiolone 7-kinase (EC 2.7.1.188) is involved in the biosynthesis of the oligosaccharide acarbose.
Cat. No.: HY-E71526
Target:
Research Areas:
2-epi-5-epi-Valiolone 7-phosphate 2-epimerase (EC 5.1.3.35) is involved in the biosynthesis of the α-glucosidase inhibitor acarbose.
Cat. No.: HY-181476
CAS No.: 3095548-30-1
Target:
Research Areas:
α-Glucosidase-IN-113 is an α-glucosidase inhibitor with an IC50 of 17.52 μM. α-Glucosidase-IN-113 shows antiglycating activity and inhibits advanced glycation end-product formation. α-Glucosidase-IN-113 can be used for the research of type 2 diabetes .
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
